These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24565770)

  • 21. Evaluation of asthma control using Global Initiative for Asthma criteria and the Asthma Control Test in Uganda.
    Serugendo AN; Kirenga BJ; Hawkes M; Nakiyingi L; Worodria W; Okot-Nwang M
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):371-6. PubMed ID: 24670578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking as a predictor for loosing control of treated bronchial asthma.
    Mihăicuţă S; Ursoniu S; Dumitriu D; Frenţ S; Firă-Mladinescu O; Tudorache V
    Pneumologia; 2009; 58(3):186-9. PubMed ID: 19817317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, controlled trial of a simple emergency department intervention to improve the rate of primary care follow-up for patients with acute asthma exacerbations.
    Baren JM; Shofer FS; Ivey B; Reinhard S; DeGeus J; Stahmer SA; Panettieri R; Hollander JE
    Ann Emerg Med; 2001 Aug; 38(2):115-22. PubMed ID: 11468604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States.
    Colice GL; Ostrom NK; Geller DE; Anolik R; Blaiss M; Marcus P; Schwartz J; Nathan RA
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):157-62. PubMed ID: 22374197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scheduled asthma management in general practice generally improve asthma control in those who attend.
    Backer V; Bornemann M; Knudsen D; Ommen H
    Respir Med; 2012 May; 106(5):635-41. PubMed ID: 22349066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
    Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W
    J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of persistent asthma in Spain: associated factors.
    Díez Jde M; Barcina C; Muñoz M; Leal M
    J Asthma; 2008 Nov; 45(9):740-6. PubMed ID: 18972288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of patient outcomes with level of asthma control.
    Gold LS; Smith N; Allen-Ramey FC; Nathan RA; Sullivan SD
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):260-265.e2. PubMed ID: 23010232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of asthma in the Maghreb: results of the AIRMAG study.
    Benkheder A; Bouacha H; Nafti S; Taright S; El Ftouh M; Yassine N; Fakhfakh H; Ali-Khoudja M; Texier N; El Hasnaoui A
    Respir Med; 2009 Dec; 103 Suppl 2():S12-20. PubMed ID: 20122624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.
    Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S;
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community.
    Armour C; Bosnic-Anticevich S; Brillant M; Burton D; Emmerton L; Krass I; Saini B; Smith L; Stewart K
    Thorax; 2007 Jun; 62(6):496-502. PubMed ID: 17251316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma.
    Tomita K; Sano H; Iwanaga T; Ishihara K; Ichinose M; Kawase I; Kimura H; Hirata K; Fujimura M; Mishima M; Tohda Y
    J Asthma; 2012 Apr; 49(3):253-9. PubMed ID: 22376075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overall asthma control: the relationship between current control and future risk.
    Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
    J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
    Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
    Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes.
    Schatz M; Zeiger RS; Vollmer WM; Mosen D; Mendoza G; Apter AJ; Stibolt TB; Leong A; Johnson MS; Cook EF
    Chest; 2006 Jul; 130(1):43-50. PubMed ID: 16840381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of asthma control with health care utilization: a prospective evaluation.
    Vollmer WM; Markson LE; O'Connor E; Frazier EA; Berger M; Buist AS
    Am J Respir Crit Care Med; 2002 Jan; 165(2):195-9. PubMed ID: 11790654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations.
    Cajigal S; Wells KE; Peterson EL; Ahmedani BK; Yang JJ; Kumar R; Burchard EG; Williams LK
    J Allergy Clin Immunol Pract; 2017; 5(1):121-127.e2. PubMed ID: 27544712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
    J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.